Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$4.9B
93M shares
52-week range
$35.24 – $53.03
92% from low
Sector
ACCIDENT & HEALTH INSURANCE
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.31B | $4.02B | $3.82B | $4.12B | $3.58B | $4.15B | $4.45B | $4.49B |
| Cost of revenue | $3.73B | $2.78B | $2.54B | $2.42B | $1.79B | $2.61B | $2.74B | $2.48B |
| Gross profit | $580.2M | $1.23B | $1.28B | $1.70B | $1.79B | $1.53B | $1.70B | $2.01B |
| Gross margin | 13.5% | 30.7% | 33.6% | 41.2% | 50.1% | 37.0% | 38.3% | 44.8% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$264.8M | $274.2M | $344.3M | $733.1M | $816.5M | $356.8M | $518.3M | $293.4M |
| EBITDA | $177.2M | $694.4M | $757.0M | $1.07B | $1.20B | $862.8M | $1.07B | $842.8M |
| Net income | −$315.0M | $409.4M | $301.8M | $570.3M | $630.6M | $276.5M | $404.0M | $229.3M |
| Net margin | -7.3% | 10.2% | 7.9% | 13.8% | 17.6% | 6.7% | 9.1% | 5.1% |
| EPS (diluted) | -1.90 | 2.61 | 2.11 | 3.36 | 5.36 | 2.40 | 3.74 | 2.35 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $4.1B | $4.46 | $4.45–$4.47 | 3 |
| 2027 | $4.2B | $4.96 | $4.86–$5.07 | 3 |
| 2028 | $4.3B | $5.53 | $5.36–$5.71 | 2 |
| 2029 | $4.6B | $6.35 | $6.27–$6.43 | 1 |
Forward consensus · source: Financial Modeling Prep
CNO Financial Group Inc is a holding company for a group of insurance companies that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
www.cnoinc.comNo one on the platform currently holds CNO.
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 188,785 | $7.8M |
| Renaissance Technologiesas of 2025-03-31 | 9,700 | $404.0K |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-10 | $0.1800 | 2026-06-24 |
| 2026-03-10 | $0.1700 | 2026-03-24 |
| 2025-12-10 | $0.1700 | 2025-12-23 |
| 2025-09-10 | $0.1700 | 2025-09-24 |
| 2025-06-10 | $0.1700 | 2025-06-24 |
| 2025-03-10 | $0.1600 | 2025-03-24 |
| 2024-12-10 | $0.1600 | 2024-12-24 |
| 2024-09-10 | $0.1600 | 2024-09-24 |
| 2024-06-10 | $0.1600 | 2024-06-24 |
| 2024-03-07 | $0.1500 | 2024-03-22 |
No one on the platform has traded CNO yet.
| $7.8B |
| — |
| FGF&G Annuities & Life, Inc. | $26.48 | -1.87% | $3.5B | — |
| FHIFederated Hermes, Inc. | $55.90 | -0.98% | $4.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-12-07 |
| $0.1500 |
| 2023-12-22 |
| 2023-09-07 | $0.1500 | 2023-09-22 |
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 18.0× earnings vs its 8.3× historical median P/E.
Fair value ≈ $23.66 · price $51.52 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$CNO Excellent article that nails exactly where CNO stands right now. So if you want to update your CNO knowledge or get acquainted with CNO, this is a must read. https://everyticker.com/quote/CNO/analysis/bermuda-optimization-meets-medicare-tailwind-cno-financial-s-roe-inflection-story-nyse-cno
View on StockTwits ↗Narrow-tech-only-market angst? Check out 52-week highs in Financials $ALL $BEN $CBOE $CNO $VOYA
View on StockTwits ↗Wall St is expecting 1.02 EPS for $CNO Q2 [Reporting 08/03 AMC] http://www.estimize.com/intro/cno?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗$CNO Share Price: $45.67 Contract Selected: Sep 18, 2026 $45 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.73 – $0.89 Potential Upside: 62% ROI Time to Expiration: 136 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$CNO Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.40 up 90.48% YoY • Reported revenue of $1.03B up 2.54% YoY
View on StockTwits ↗$CNO quietly building a steady growth story. 📈 Rising life and health premiums, higher fee income, and ongoing tech investments are helping position the company for steady earnings growth through 2027. See why this stock could be worth adding 👉 https://www.zacks.com/stock/news/2881821/heres-why-you-should-add-cno-financial-to-your-portfolio-now?cid=sm-stocktwits-2-2881821-teaser-36825&ADID=SYND_STOCKTWITS_TWEET_2_2881821_TEASER_36825
View on StockTwits ↗$CNO poised for growth — here's why it's a compelling buy! 🚀 With a Zacks Rank #2 (Buy), CNO Financial is backed by strong collected premiums and a high-quality portfolio, contributing to projected earnings increases of 7.4% in 2026 and 9.9% in 2027. Shares have climbed 5.3% in the past year, outpacing the industry’s decline. 📈 Discover the full investment case here 👉 https://www.zacks.com/stock/news/2881821/heres-why-you-should-add-cno-financial-to-your-portfolio-now?cid=sm-stocktwits-2-2881821-body-36824&ADID=SYND_STOCKTWITS_TWEET_2_2881821_BODY_36824
View on StockTwits ↗$CNO Current Stock Price: $43.20 Contracts to trade: $43.0 CNO Feb 20 2026 Call Entry: $0.77 Exit: $0.97 ROI: 27% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$CNO Share Price: $43.06 Contract Selected: Sep 18, 2026 $33.0 Calls Buy Zone: $7.22 – $8.93 Target Zone: $12.15 – $14.86 Potential Upside: 59% ROI Time to Expiration: 217 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗Premiums came through — and the earnings beat followed 💰 CNO Financial ($CNO) delivered a Q4 earnings beat as higher collected premiums across annuity, life, and health products lifted results, even with rising costs in the mix. Solid top-line execution doing the heavy lifting. See what drove the upside this quarter 👉 https://www.zacks.com/stock/news/2837799/cno-beats-q4-earnings-estimates-on-higher-collected-premiums?cid=sm-stocktwits-2-2837799-teaser-32494&ADID=SYND_STOCKTWITS_TWEET_2_2837799_TEASER_32494
View on StockTwits ↗$CNO beats Q4 estimates — what's driving the growth? 🚀 CNO Financial reported a 22.5% EPS beat with strong collected premiums from annuity, life, and health products. However, rising expenses slightly dampened the upside 📉. Discover the full insights here 👉 https://www.zacks.com/stock/news/2837799/cno-beats-q4-earnings-estimates-on-higher-collected-premiums?cid=sm-stocktwits-2-2837799-body-32471&ADID=SYND_STOCKTWITS_TWEET_2_2837799_BODY_32471
View on StockTwits ↗$CNO Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.98 down -44.94% YoY • Reported revenue of $101.1M down -90.79% YoY • CNO Financial Group enters 2026 with a strong capital position and is on a path to achieving its 2027 ROE target. The company achieved or exceeded all 2025 guidance metrics.
View on StockTwits ↗$CNO senior-focused insurer, interest rate sensitive
View on StockTwits ↗Wall St is expecting 0.93 EPS for $CNO Q1 [Reporting 05/04 AMC] http://www.estimize.com/intro/cno?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗$CNO Momentum remains fragile and reacts quickly to operational clarity; free‑cash‑flow conversion needs to normalize — execution across cycles would support multiple expansion. From here, results — not promises — will decide direction.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.